EDGAR Filing Documents for 0001144204-14-015394

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001144204-14-015394

Filing Date

2014-03-13

Accepted

2014-03-13 13:56:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	v371500_posam.htm	POS AM	685080
2	EXHIBIT 23.1	v371500_ex23-1.htm	EX-23.1	2537
	Complete submission text file	0001144204-14-015394.txt		688692

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-187826 | Film No.: 14690467
SIC: 2834 Pharmaceutical Preparations